SECURE-AD: Update on the Analysis of COVID-19 Effects on People with Atopic Dermatitis

Globally, 21 atopic dermatitis patient organisations have become official partners of SECURE-AD, two international COVID-19 surveys for atopic dermatitis (also known as AD or eczema) . One survey is for healthcare providers and the other is for individuals with AD. What is the SECURE-AD Patient Survey? The SECURE-AD Patient Survey allows patients with AD who […]